Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR
Public ClinicalTrials.gov record NCT04447820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open-Label, 4-Week Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Once Daily Treatment Compared to K-877-IR Twice Daily Treatment in Adult Patients With Fasting Triglyceride Levels
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study to evaluate the efficacy of K-877 extended release (ER) once daily (QD) compared to K-877 immediate release (IR) twice daily (BID).
Study identification
- NCT ID
- NCT04447820
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 96 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2020 (Actual)
- Primary completion
- Dec 3, 2020 (Actual)
- Completion
- Dec 3, 2020 (Actual)
- Last update posted
- Dec 22, 2023
2020
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Research Group | Anniston | Alabama | 36207 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Columbus Regional Health | Columbus | Georgia | 31904 | — |
| Prism Research | Saint Paul | Minnesota | 55114 | — |
| Diabetes and Endocrinology Consultants, P.C. | Morehead City | North Carolina | 28557 | — |
| Medpace Clinical Pharmacology, LLC | Cincinnati | Ohio | 45227 | — |
| Aventiv Research, Inc. | Columbus | Ohio | 43213 | — |
| Summit Research Group, LLC | Munroe Falls | Ohio | 44262 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04447820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04447820 live on ClinicalTrials.gov.